BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12773116)

  • 1. Proopiomelanocortin gene expression and DNA methylation: implications for Cushing's syndrome and beyond.
    Newell-Price J
    J Endocrinol; 2003 Jun; 177(3):365-72. PubMed ID: 12773116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CpG island promoter of the human proopiomelanocortin gene is methylated in nonexpressing normal tissue and tumors and represses expression.
    Newell-Price J; King P; Clark AJ
    Mol Endocrinol; 2001 Feb; 15(2):338-48. PubMed ID: 11158338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypomethylation in the promoter region of POMC gene correlates with ectopic overexpression in thymic carcinoids.
    Ye L; Li X; Kong X; Wang W; Bi Y; Hu L; Cui B; Li X; Ning G
    J Endocrinol; 2005 May; 185(2):337-43. PubMed ID: 15845926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E2F1-mediated human POMC expression in ectopic Cushing's syndrome.
    Araki T; Liu NA; Tone Y; Cuevas-Ramos D; Heltsley R; Tone M; Melmed S
    Endocr Relat Cancer; 2016 Nov; 23(11):857-870. PubMed ID: 27935805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two Distinctive POMC Promoters Modify Gene Expression in Cushing Disease.
    Araki T; Tone Y; Yamamoto M; Kameda H; Ben-Shlomo A; Yamada S; Takeshita A; Yamamoto M; Kawakami Y; Tone M; Melmed S
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3346-e3363. PubMed ID: 34061962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synthesis of ACTH and related peptides by tumours.
    White A; Clark AJ; Stewart MF
    Baillieres Clin Endocrinol Metab; 1990 Mar; 4(1):1-27. PubMed ID: 2167656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early-life stress reduces DNA methylation of the Pomc gene in male mice.
    Wu Y; Patchev AV; Daniel G; Almeida OF; Spengler D
    Endocrinology; 2014 May; 155(5):1751-62. PubMed ID: 24506071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal alcohol exposure alters proopiomelanocortin gene expression and hypothalamic-pituitary-adrenal axis function via increasing MeCP2 expression in the hypothalamus.
    Gangisetty O; Bekdash R; Maglakelidze G; Sarkar DK
    PLoS One; 2014; 9(11):e113228. PubMed ID: 25409090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable modes of proopiomelanocortin gene transcription in human tumors.
    de Keyzer Y; Bertagna X; Luton JP; Kahn A
    Mol Endocrinol; 1989 Jan; 3(1):215-23. PubMed ID: 2536890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pro-opiomelanocortin mRNA size heterogeneity in ACTH-dependent Cushing's syndrome.
    Clark AJ; Lavender PM; Besser GM; Rees LH
    J Mol Endocrinol; 1989 Jan; 2(1):3-9. PubMed ID: 2765113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid-dependent ACTH-produced thymic carcinoid: regulation of POMC gene expression by cortisol via methylation of its promoter region.
    Mizoguchi Y; Kajiume T; Miyagawa S; Okada S; Nishi Y; Kobayashi M
    Horm Res; 2007; 67(5):257-62. PubMed ID: 17220632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of dopaminergic control on melanotrophs leads to Cushing's-like syndrome in mice.
    Saiardi A; Borrelli E
    Mol Endocrinol; 1998 Aug; 12(8):1133-9. PubMed ID: 9717839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of proopiomelanocortin gene transcription mechanisms in bronchial tumour cells.
    Picon A; Bertagna X; de Keyzer Y
    Mol Cell Endocrinol; 1999 Jan; 147(1-2):93-102. PubMed ID: 10195696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-specific helix-loop-helix factor required for pituitary expression of the pro-opiomelanocortin gene.
    Therrien M; Drouin J
    Mol Cell Biol; 1993 Apr; 13(4):2342-53. PubMed ID: 8455616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothalamic proopiomelanocortin promoter methylation becomes altered by early overfeeding: an epigenetic model of obesity and the metabolic syndrome.
    Plagemann A; Harder T; Brunn M; Harder A; Roepke K; Wittrock-Staar M; Ziska T; Schellong K; Rodekamp E; Melchior K; Dudenhausen JW
    J Physiol; 2009 Oct; 587(Pt 20):4963-76. PubMed ID: 19723777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of the POMC promoter region in pituitary and extrapituitary ACTH producing tumors.
    Mönig H; Ali IU; Oldfield EH; Schulte HM
    Exp Clin Endocrinol; 1993; 101(1):36-8. PubMed ID: 8386673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 60 YEARS OF POMC: Transcriptional and epigenetic regulation of POMC gene expression.
    Drouin J
    J Mol Endocrinol; 2016 May; 56(4):T99-T112. PubMed ID: 26792828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of the human pro-opiomelanocortin promoter in the small cell lung carcinoma cell line DMS-79.
    Picon A; Leblond-Francillard M; Raffin-Sanson ML; Lenne F; Bertagna X; de Keyzer Y
    J Mol Endocrinol; 1995 Oct; 15(2):187-94. PubMed ID: 8800643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of DNA elements cooperatively activating proopiomelanocortin gene expression in the pituitary glands of transgenic mice.
    Liu B; Hammer GD; Rubinstein M; Mortrud M; Low MJ
    Mol Cell Biol; 1992 Sep; 12(9):3978-90. PubMed ID: 1508198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional regulation of pituitary POMC is conserved at the vertebrate extremes despite great promoter sequence divergence.
    Bumaschny VF; de Souza FS; López Leal RA; Santangelo AM; Baetscher M; Levi DH; Low MJ; Rubinstein M
    Mol Endocrinol; 2007 Nov; 21(11):2738-49. PubMed ID: 17698954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.